Ascendent Capital Partners has closed its third China fund with more than $1 billion in commitments, having increased the hard cap.
Chinese smart sensor maker Hesai Technology has raised a $173 million Series C round led by Germany’s Bosch Group and existing investor Lightspeed China Partners.
Shanghai Kechow Pharma, a Chinese small molecule targeted drug developer, has raised a $45 million Series C round led by Decheng Capital.
Baibu, a Chinese B2B trading and services platform for the textiles and fabrics industry, has raised a $300 million Series D round led by DST Global.
Chinese commercial space launch service provider LandSpace has raised a RMB500 million ($71 million) Series C led by the VC arm of Hong Kong-listed property developer Country Garden.
Apis Partners has closed its second emerging markets-focused financial services and technology fund at the revised hard cap of $563 million. The initial target was $400 million.
GLP, a private equity-owned warehouse operator based in Singapore, has set up a China logistics fund at RMB15 billion ($2.1 billion).
IFC has proposed to invest up to $30 million in the latest fund from Vietnam-based private equity firm Mekong Capital.
The Australian government has launched a A$540 million ($365 million) growth fund to support small and medium-sized enterprises (SMEs), with commitments coming from the country's largest banks.
Newlinks Group, operator of the Chezhubang platform that helps drivers in China locate the best value gas stations, has raised a $110 million Series C round led by Joy Capital.
Medbanks, a Chinese oncology database platform, has raised around RMB1 billion ($140 million) in an extended Series D funding round led by Tencent Holdings and Wu Capital.
Primavera Capital Group has closed its third China fund at $3.4 billion, having extended the fundraising period by six months.
Singapore private equity firm Tembusu Partners has received a strategic commitment of up to RMB670 million ($96 million) for a RMB2 billion fund targeting the liquor industry in China’s Guizhou province.
China International Capital Corporation (CICC) and global pharmaceutical giant AstraZeneca are looking to raise $1 billion for a fund that will back Chinese healthcare companies as well as international players looking to enter the country.
SoftBank founder Masayoshi Son admitted to a lapse in judgment on WeWork while disclosing that SoftBank Vision Fund and SoftBank Group have written down their positions in the beleaguered co-working space provider by a combined $7.7 billion.
Investcorp has teamed up with China Resources and Fung Investments, the private investment arm of the founding family of Hong Kong consumer goods and supply chain conglomerate Fung Group, to raise a $500 million Asia food fund.
China Everbright and Investcorp have agreed to combine their respective China technology-focused investment teams and co-manage a recently launched fund targeting the sector.
KKR plans to raise a growth-stage technology fund focused on Asia, expanding a strategy that is already operational in North America, Europe, and Israel.
Taimei Technology, a Chinese cloud-based software provider that serves pharmaceutical companies and clinical research organizations (CROs) has raised RMB1.5 billion ($212 million) through an extended Series E round of funding.
Mekong Capital has launched its fifth private equity fund focused on the Vietnam middle market. A hard cap has been set at $250 million.
Vertex Venture Holdings, the VC arm of Singapore’s Temasek Holdings, has reached a final close on its first growth-stage fund with $290 million in commitments. The initial target was $250 million.
China-Europe cross-border private equity firm Mandarin Capital Partners has reached a first close of EUR148 million ($163 million) on its third fund. The overall target is EUR250 million.
China-based food and agriculture specialist Hosen Capital is looking to raise $750 million for its fourth fund.
Ou Wang, the former head of private equity for China Investment Corporation (CIC), has joined China Renaissance Holdings as a strategy consultant. He has also joined the board of Huajing Securities, the firm’s mainland China-focused investment banking...